In an article printed in BioPharma Dive, Martin Roessner, Vice President, Biostatistics at Parexel discusses adaptive trial designs, their impact on clinical research, the challenges biopharmaceutical companies face implementing them and how to overcome that, recent FDA guidelines and more.
Other content in this Stream
Learn about common-sense strategies that can help employ adaptive trial designs.
This PharmaVoice podcast explores adaptive trial designs as a key innovation that, when used, can increase the likelihood of drug launch, particularly in oncology trials.
Learn how Parexel can help you successfully implement Adaptive Trial Designs.